Although this FANCC germline mutation was rare, it might have important clinic implications since FANCC is a breast cancer suppressor and is responsible for FA complementation group C. The number of identified genes responsible for moderate to high-risk susceptibility of breast cancer is increasing, which can account for ~ 1% of the affected families. The gene discussed is FANCC; the disease is breast carcinoma.